USFDA approves expanded use of AstraZeneca cancer drug Ruby Khatun Khatun14 Jan 2018 10:15 AM ISTThe U.S. Food and Drug Administration said on Friday it has approved expanded use of AstraZeneca Plc’s cancer drug Lynparza to include patients with...
Plan to reduce medicine prices faces industry pushback: Report Ruby Khatun Khatun14 Jan 2018 10:08 AM ISTIndia’s proposal to curb drug prices by stripping generic medicines of their brand names has stalled after the plan faced pushback from the country’s...
Roche's star MS medicine Ocrevus wins EU approval Ruby Khatun Khatun14 Jan 2018 9:45 AM ISTZURICH: The European Union approved Roche’s multiple sclerosis medicine Ocrevus, one the Swiss company’s key new drugs that likely neared $1 billion...
Merck Foundation partners with Malaysia and India to build healthcare capacity in Africa Ruby Khatun Khatun14 Jan 2018 9:30 AM ISTNew Delhi: Merck Foundation (MF), a non-profit company and subsidiary of Merck KGaA Germany, and the University of Malaya (UM), Malaysia's oldest and...
First: Health Ministry Panel wants JnJ to pay at least Rs 20 lakh to patients for faulty implants Ruby Khatun Khatun13 Jan 2018 4:07 PM ISTNew Delhi: Compensation has been recommended by a panel set up by the health ministry, in order to provide relief to patients who received faulty hip...
Sun Pharma’s Halol facility gets clearance from Dutch drug regulator Ruby Khatun Khatun13 Jan 2018 11:00 AM ISTMumbai: Sun Pharma, the largest pharma company by revenue and market share in India, has received a clearance for its Halol facility from a Dutch drug...
Eyeing over 80 percent sales from US, India, Europe by 2021: Glenmark Ruby Khatun Khatun13 Jan 2018 10:30 AM ISTNew Delhi: Glenmark Pharmaceuticals said it expects the US, Indian and European markets, along with active pharmaceutical ingredient (API) segment, to...
How biotech CEO John Hood turned failed Sanofi drug into multibillion deal Ruby Khatun Khatun13 Jan 2018 9:30 AM ISTIn April 2016, John Hood went and told his wife that he had put down a quarter million dollars of their money to try and buy back a drug he’d helped...
Domestic medical device makers seek hike in basic custom duty Ruby Khatun Khatun12 Jan 2018 11:00 AM ISTNew Delhi: The government needs to increase the basic customs duty on medical devices in the range of 5-15 percent to promote domestic manufacturing,...
More trouble for Sanofi: Philippines exhumes bodies of two children in dengue vaccine probe Ruby Khatun Khatun12 Jan 2018 10:45 AM ISTMANILA: A Philippine government agency on Thursday exhumed the bodies of two children whose parents suspect they died of dengue after receiving a new...
Roche plea in HC on cancer drug not maintainable: Biocon, Mylan Ruby Khatun Khatun12 Jan 2018 10:27 AM ISTNew Delhi: Generic drug makers Biocon and Mylan told the Delhi High Court that Swiss pharma major Roche's civil suit, challenging DCGI approvals...
Abbott and YRGCARE join hands to study HIV, hepatitis patterns Ruby Khatun Khatun12 Jan 2018 10:15 AM ISTMumbai: Strengthening India's efforts in combating HIV and hepatitis viruses, pharma firm Abbott Ltd has announced its partnership with YR Gaitonde...
